Clinical trials with steril preparations. Analysis of Spain clinical trial registry

Q Pharmacology, Toxicology and Pharmaceutics Anales De La Real Academia Nacional De Farmacia Pub Date : 2022-10-10 DOI:10.53519/analesranf.2022.88.03.04
Alberto García Rojo de Cózar
{"title":"Clinical trials with steril preparations. Analysis of Spain clinical trial registry","authors":"Alberto García Rojo de Cózar","doi":"10.53519/analesranf.2022.88.03.04","DOIUrl":null,"url":null,"abstract":"Objective: To review the legal regime for sterile products preparation in the context of clinical trials.\nMethod: A literature review of different rules, guideliness and reports from different organisms has been completed. Furthermore, an analysis of Spanish Clinical Trials Registry (REec) was performed in order to know the trend of what is the type of clinical trials that are being conducted in Spain.\nResults: at Europe Union there is not a specific regulation about this matter, being a member state responsibiliy to have a local law. In Spain, there is a guideline regarding Good Practices of preparation for drugs on Hospital Pharmacy Services. Spain Clinical Trials Registry analysis indicates that approximately 50% of studies could requiered that those study drugs to be pre-pared on sterile conditions, and on this group, 79% are international studies.\nConclusions: Spain has solid regulations on sterile preparation drugs for routine practice and for clinical research drugs. All professionals involved in clinical research should be aware of these regulations in order to maintain Spain’s position of excellence in clinical research at the international level.","PeriodicalId":50795,"journal":{"name":"Anales De La Real Academia Nacional De Farmacia","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anales De La Real Academia Nacional De Farmacia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53519/analesranf.2022.88.03.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To review the legal regime for sterile products preparation in the context of clinical trials. Method: A literature review of different rules, guideliness and reports from different organisms has been completed. Furthermore, an analysis of Spanish Clinical Trials Registry (REec) was performed in order to know the trend of what is the type of clinical trials that are being conducted in Spain. Results: at Europe Union there is not a specific regulation about this matter, being a member state responsibiliy to have a local law. In Spain, there is a guideline regarding Good Practices of preparation for drugs on Hospital Pharmacy Services. Spain Clinical Trials Registry analysis indicates that approximately 50% of studies could requiered that those study drugs to be pre-pared on sterile conditions, and on this group, 79% are international studies. Conclusions: Spain has solid regulations on sterile preparation drugs for routine practice and for clinical research drugs. All professionals involved in clinical research should be aware of these regulations in order to maintain Spain’s position of excellence in clinical research at the international level.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
无菌制剂的临床试验。西班牙临床试验注册分析
目的:综述临床试验中无菌产品制备的法律制度。方法:对不同生物的不同规则、指南和报道进行文献综述。此外,还对西班牙临床试验登记处(REec)进行了分析,以了解西班牙正在进行的临床试验类型的趋势。结果:在欧盟没有关于这个问题的具体规定,作为成员国的责任有当地的法律。在西班牙,有一项关于医院药房服务药品配制良好做法的指导方针。西班牙临床试验登记处的分析表明,大约50%的研究可能要求这些研究药物在无菌条件下制备,在这一组中,79%是国际研究。结论:西班牙对常规执业和临床研究用无菌制剂药品有较为完善的规定。所有参与临床研究的专业人员都应该了解这些法规,以保持西班牙在国际水平上临床研究的卓越地位。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.13
自引率
0.00%
发文量
7
期刊介绍: The Anales de la Real Academia Nacional de Farmacia� embraces all aspects of pharmaceutical sciences and is a quarterly journal that publishes basic and applied research on pharmaceutical sciences and related areas. It is a medium for reporting selected original and significant contributions to new pharmaceutical knowledge.
期刊最新文献
Therapeutic repositioning: importance of new therapeutic indications approved for old medicines The mRNA COVID 19 vaccine: More than a drug? Detection and management of a case of drug-resistant hypertension Galenic development of a capsule containing rosuvastatin, repaglinide, and olmesartan mini-tablets for the treatment of metabolic syndrome Novel drugs recently authorized by ema and fda (Q2, 2024)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1